Por favor, use este identificador para citar o enlazar este ítem:
https://hdl.handle.net/11000/35259
Evolution of the Use of Corticosteroids for the Treatment of Hospitalised COVID-19 Patients in Spain between March and November 2020: SEMI-COVID National Registry
Título : Evolution of the Use of Corticosteroids for the Treatment of Hospitalised COVID-19 Patients in Spain between March and November 2020: SEMI-COVID National Registry |
Autor : Balaz, David Wikman-Jorgensen, Philip Erick  Giner Galvañ, Vicente Rubio-Rivas, Manuel  de Miguel-Campo, Borja  Noureddine López, Mariam  López Caleya, Juan Francisco  Gómez Huelgas, Ricardo  Pesqueira Fontán, Paula María Méndez Bailón, Manuel Fernández-Garcés, Mar  Fernádez-Cruz, Ana García García, Gema María Rhyman, Nicolás Corral-Gudino, Luis  |
Editor : MDPI |
Departamento: Departamentos de la UMH::Medicina Clínica |
Fecha de publicación: 2021-10-08 |
URI : https://hdl.handle.net/11000/35259 |
Resumen :
Objectives: Since the results of the RECOVERY trial, WHO recommendations about the use
of corticosteroids (CTs) in COVID-19 have changed. The aim of the study is to analyse the evolutive
use of CTs in Spain during the pandemic to assess the potential influence of new recommendations.
Material and m... Ver más |
Palabras clave/Materias: COVID-19 corticosteroids Spain comorbidities |
Tipo de documento : info:eu-repo/semantics/article |
Derechos de acceso: info:eu-repo/semantics/openAccess Attribution-NonCommercial-NoDerivatives 4.0 Internacional |
DOI : 10.3390/jcm10194610 |
Publicado en: J Clin Med . 2021 Oct 8;10(19):4610 |
Aparece en las colecciones: Artículos Medicina Clínica
|
La licencia se describe como: Atribución-NonComercial-NoDerivada 4.0 Internacional.